 
Bio Stem Technologies Accelerates Into 2026 With Transformative Acquisition, Seven Straight Profitable Quarters, and Entry into Advanced and Acute Wound Care Markets! BioStem Technologies (OTCQB: BSEM) is emerging as one of the most compelling small-cap MedTech companies as 2026 begins. The company just completed the acquisition of BioTissue Holdings’ surgical and wound care business, instantly expanding its footprint into hospital-based, acute, and surgical wound care. With established product lines like Neox® and Clarix®, a nationwide sales force, and key GPO contracts, BioStem is now positioned to capture a $300–$350 million addressable market, spanning chronic and acute wound care, burns, and soft-tissue repair. Zacks Small Cap Research has assigned BSEM a $25.50 price target, highlighting confidence in the company’s profitable growth, clinical validation, and expanding market presence. Coupled with seven consecutive profitable quarters, strong gross margins of 88.5%, and $16 million in cash post-acquisition, BSEM is demonstrating operational excellence rarely seen in small-cap regenerative medicine. Backed by clinically validated BioREtain® technology, FDA-level studies, and a potential Nasdaq uplisting in mid-2026, BSEM is gaining traction with both institutional investors and healthcare providers. Discover why BSEM is setting the standard for profitable, clinically proven MedTech growth in 2026
Tuesday's Bonus Story Monolithic Power Systems Is Surging—Has Valuation Caught Up?Submitted by Leo Miller. Article Published: 2/10/2026. 
Key Points- While other top chip stocks have lagged over recent months, Monolithic Power Systems continues to come through for investors.
- The company is now firing on all cylinders, having seen strong growth across all end markets last quarter.
- However, when it comes to achieving further upside, what is the outlook for MPWR shares?
- Special Report: Silver records prices are great. Monthly income is better (From Investors Alley)
Over the past three months, some of the biggest names in the semiconductor industry have slowed. NVIDIA (NASDAQ: NVDA) is up just 1% over that period, Broadcom (NASDAQ: AVGO) is down 1%, and Advanced Micro Devices (NASDAQ: AMD) is down more than 7%. That hasn't been the case for the high-flying chip stock Monolithic Power Systems (NASDAQ: MPWR). The shares have returned 26% over the past three months and 69% over the past 52 weeks. I Called Black Monday. Now I'm Calling March 26!
I predicted the 1987 crash six weeks early. I called the fall of the Berlin Wall. I pinpointed the exact bottom in 2009.
Now I'm staking my reputation on March 26, 2026 - the day I believe Elon will announce the SpaceX IPO.
Bloomberg is calling it "the biggest listing of ALL TIME."
A $1.5 TRILLION valuation... the "wealth-building" moment of the decade.
Today, I'll show you how to get in before the big announcement. Click Here to See How to Secure Your "SpaceX Access Code" Monolithic posted its latest financial results on Feb. 5, which helped justify the stock's strong rally. After such a big run, is there still a meaningful opportunity in MPWR shares going forward? MPWR Gets a Lift After Rock-Solid Earnings ReportIn Q4 2025, Monolithic reported revenue of $751 million, up 21% year over year. That comfortably exceeded estimates of roughly $742 million (about 19% growth). Adjusted earnings per share were $4.79, a 17% increase that beat consensus of $4.74 (16% growth). The company's full-year performance was notable. Revenue rose more than 26%, its fastest growth since 2022, and operating margin improved by 60 basis points to a very strong 35.2%. Sales in five of Monolithic's six end markets grew by 25% or more; enterprise data was the lone laggard, with sales down 2%. By Q4, every end market was growing at least 15% year over year. In 2025, three of those end markets each accounted for at least 20% of total revenue, underscoring the company's diversified customer base. Markets rewarded Monolithic after the Feb. 5 release, with shares rising 6.4% the next day. Monolithic Raises Data Center Forecasts, Sends 800 VDC SamplesLooking ahead, Monolithic sees revenue growth of more than 22% at the midpoint of its Q1 2026 guidance—well above forecasts that expected just 16% growth. The company says demand is robust, with its book-to-bill ratio coming in "well in excess of one" last quarter. That indicates Monolithic received more orders than it shipped, and its backlog now extends into Q3 2026. The enterprise data segment, which includes data center sales, is especially strong: the company raised its 2026 sales-growth estimate for this market from 30–40% to at least 50%. Looking further out, Monolithic has a sizable opportunity in 800-volt direct-current (VDC) data-center architecture—an emerging power-delivery system that NVIDIA is championing. The company says it was the first to send product samples as it competes for 800 VDC business. Revenue from that opportunity likely wouldn't arrive until late 2027 or beyond, but the update signals Monolithic's technical readiness to pursue high-value contracts. Monolithic: Fantastic Executor, Premium ValuationOverall, Monolithic Power Systems looks like an excellent business. The chief concern is valuation: the current share price assumes very high free-cash-flow growth for many years. Even with strong data-center tailwinds and a diversified customer base, that sets a demanding bar. Any execution misstep at MPWR could produce a meaningful sell-off, since investors are pricing in lofty expectations. The MarketBeat consensus price target for Monolithic sits near $1,218, implying about 1% upside. Analysts who issued updated targets after the earnings report are more bullish, averaging $1,309 (roughly 8% upside). Rosenblatt Securities' updated $1,000 target implies about 17% downside, while KeyCorp's $1,500 target implies roughly 24% upside. Despite valuation risks, Monolithic remains a high-quality company with long-term growth potential. Advances in power-regulation chips and systems are essential to enabling technological progress across many parts of the economy, and Monolithic is well positioned to benefit.
This message is a paid advertisement for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency and Huge Alerts. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $12,500. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Sideways Frequency or Huge Alerts. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts' website for additional information about the relationship between Huge Alerts and BioStem Technologies Inc. (OTC: BSEM). | 
No comments:
Post a Comment